Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010 | Infection Control & Hospital Epidemiology | Cambridge Core (original) (raw)

References

  1. Hidron, AI, Edwards, JR, Patel, J, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29(11): 996–1011. Erratum in _Infect ControlHosp Epidemiol_2009;30(1): 107.CrossRefGoogle Scholar

  2. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing-sixteenth informational supplement. Wayne, PA: CLSI, 2008. CLSI document M100-S18.Google Scholar

  3. Magiorakos, A-P, Srinivasan, A, Carey, RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18(3): 268–281.CrossRefGoogle ScholarPubMed

  4. Landrum, ML, Neumann, C, Cook, C, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA 2012;308(1): 50–59.CrossRefGoogle ScholarPubMed

  5. Kallen, AJ, Mu, Y, Bulens, S, et al; Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010;304(6):641–648.CrossRefGoogle ScholarPubMed

  6. Kallen, AJ, Hidron, AI, Patel, J, Srinivasan, A. Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol 2010;31(5): 528–531.CrossRefGoogle Scholar

  7. Bradley, JS, Guidos, R, Baragona, S, et al. Anti-infective research and development: problems, challenges, and solutions. Lancet 2007;7:68–78.CrossRefGoogle ScholarPubMed

  8. Lewis, JS II, Herrera, M, Wiekes, B, Patterson, JE, Jorgensen, JH. First report of the emergence of CTX-M-type extended-spectrum _β_-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 2007; 51:4015–4021.CrossRefGoogle Scholar

  9. Bradford, PA, Bratu, S, Urban, C, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 _β_-lacta-mases in New York City. Clin Infect Dis 2004;39:55–60.CrossRefGoogle Scholar

  10. Sexton, DJ, Chen, LF, Anderson, DJ. Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes? Infect Control Hosp Epidemiol 2010;31(12):1286–1289.CrossRefGoogle Scholar